Company Uni-Bio Science Group Limited

690 KYG9198H1406

Pharmaceuticals

Market Closed - Hong Kong S.E. Other stock markets 11:08:30 11/06/2026 +03			5-day change	1st Jan Change
0.0850 ^HKD	0.00%		-5.56%	-26.09%

05-26	Uni-Bio Science Group Limited Approves Final Dividend	CI
04-24	Uni-Bio Science Moves to Replace Expiring Share Option Scheme	MT

Business description: Uni-Bio Science Group Limited

Uni-Bio Science Group Ltd is an investment company mainly engaged in the manufacture and sales of pharmaceutical products. The Company operates its business through three segments. Biological Pharmaceutical Products segment is mainly engaged in the manufacture and sale of biological pharmaceutical products. Chemical Pharmaceutical Products segment is mainly engaged in the manufacture and sale of chemical pharmaceutical products. Pipeline Products segment is mainly engaged in the research and development of pharmaceutical products.

Number of employees: 543

Sales by Activity: Uni-Bio Science Group Limited

Fiscal Period: December	2021 (HKD)	2022 (HKD)	2023 (HKD)	2024 (HKD)	2025 (HKD)
Biological Pharmaceutical Products	207M	208M	227M	303M	386M
Chemical Pharmaceutical Products	147M	232M	258M	250M	200M

See all business segments

Geographical breakdown of sales: Uni-Bio Science Group Limited

Fiscal Period: December	2021 (HKD)	2022 (HKD)	2023 (HKD)	2024 (HKD)	2025 (HKD)
The People's Republic of China (PRC)	353M	440M	485M	553M	586M

See all geographic segments

Executive Committee: Uni-Bio Science Group Limited

Manager	Title	Age	Since
Zhi Gang Zhao CEO	Chief Executive Officer	66	08/04/2019
Yalei Wen COO	Chief Operating Officer	62	17/12/2024
Wei Tian ADM	Chief Administrative Officer	43	-
Jing Li CTO	Chief Tech/Sci/R&D Officer	47	-
Wing Yan Ho SEC	Corporate Secretary	44	05/09/2019

See UNI-BIO SCIENCE GROUP LIMITED governance

Composition of the Board of Directors: Uni-Bio Science Group Limited

Director	Title	Age	Since
Kingsley Leung CHM	Chairman	39	13/01/2017
Zhi Gang Zhao BRD	Director/Board Member	66	01/04/2014
Paul Chow BRD	Director/Board Member	60	01/04/2016
Da Wei Chen BRD	Director/Board Member	56	13/01/2017
Qi Min Ren BRD	Director/Board Member	70	15/11/2017
Qing Shan Ma BRD	Director/Board Member	46	08/04/2019
Kwok Wing Yau BRD	Director/Board Member	51	08/04/2019
Qing Zhang BRD	Director/Board Member	39	01/11/2024
Yalei Wen BRD	Director/Board Member	62	17/12/2024

Composition of the Board of Directors

Shareholders: Uni-Bio Science Group Limited

Name	Stocks	%	Valuation
Yi Wah Lau 26.48 %	1,580,971,464	26.48 %	18 M $
Ru Feng He 11.01 %	657,180,000	11.01 %	7 M $
Kingsley Leung 3.507 %	209,420,000	3.507 %	2 M $
Da Wei Chen 2.865 %	171,094,438	2.865 %	2 M $
Yalei Wen 2.192 %	130,893,000	2.192 %	1 M $

List of UNI-BIO SCIENCE GROUP LIMITED shareholders

Company details: Uni-Bio Science Group Limited

Uni-Bio Science Group Ltd.

Unit 502, 5/F

, Hong Kong

http://www.uni-bioscience.com

address Uni-Bio Science Group Limited(690)

Biopharmaceuticals

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
UNI-BIO SCIENCE GROUP LIMITED	0.00%	-5.56%	-5.56%	+51.79%	64.76M
REGENERON PHARMACEUTICALS, INC.	+1.93%	-2.28%	+18.47%	-18.52%	61.21B
UCB	+2.50%	+4.43%	+64.44%	+218.90%	58.15B
SAMSUNG BIOLOGICS CO.,LTD.	-0.92%	+28.60%	+28.60%	+28.60%	39.54B
CSL LIMITED	+4.16%	+16.25%	-56.08%	-64.88%	35.08B
BIOGEN INC.	+2.06%	+1.05%	+49.19%	-36.66%	28.68B
INCYTE CORPORATION	+2.88%	+7.31%	+57.79%	+74.94%	21.06B
MODERNA, INC.	+4.40%	-6.51%	+73.80%	-60.95%	18.25B
INNOVENT BIOLOGICS, INC.	-1.88%	-5.07%	-10.05%	+93.76%	16.49B
SWEDISH ORPHAN BIOVITRUM AB	+0.78%	-1.57%	+44.59%	+101.10%	15.87B
Average	+1.58%	+0.57%	+26.52%	+38.81%	29.44B
Weighted average by Cap.	+1.88%	+1.43%	+29.07%	+44.22%